Interferon (IFN)-induced gene expression
Showing 26 - 50 of >10,000
COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis
Not yet recruiting
- COVID19
- Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
- +4 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Jul 29, 2021
Skin Diseases Trial (Exposed to UV)
Not yet recruiting
- Skin Diseases
- Exposed to UV
- (no location specified)
Mar 10, 2023
Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)
Completed
- Tuberculosis
- Placebo
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Public Health clinical Center
Mar 9, 2022
Deficient T Regulatory Cell Function in Relapsing Remitting
Recruiting
- Relapse Remitting Multiple Sclerosis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jun 13, 2022
Predictive Models and Clinical Outcome of Radiation Pneumonitis
Recruiting
- Radiation Pneumonitis
- Blood Samples for Biomarkers
-
Wuhan, Hubei, China
- +2 more
Oct 5, 2022
Asthma, COPD, Exacerbation Copd Trial in Copenhagen (Azithromycin, Placebo oral tablet)
Recruiting
- Asthma
- +7 more
- Azithromycin
- Placebo oral tablet
-
Copenhagen, DenmarkUniversity Hospital Bispebjerg and Frederiksberg
Jul 23, 2021
Covid-19; SARS-Cov2 Trial (Blood sampling, Nasal Brushing)
Not yet recruiting
- Covid-19; SARS-Cov2
- Blood sampling
- Nasal Brushing
- (no location specified)
Oct 24, 2022
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Healthy Trial in Aarhus (Prednisolone)
Recruiting
- Healthy
-
Aarhus, State, DenmarkDepartment of Endocrinology and Internal Medicine
Sep 6, 2023
Structural Chromosome Rearrangements and Brain Disorders
Enrolling by invitation
- Rare Diseases
- +2 more
-
Stockholm, SwedenAnna Lindstrand
Oct 2, 2023
COVID-19 Trial in Entebbe (LNP-nCOV saRNA-02 Vaccine)
Recruiting
- COVID-19
- LNP-nCOV saRNA-02 Vaccine
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
Apr 14, 2022
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Anti-interferon Autoantibodies on Viral Load in Severe
Not yet recruiting
- Severe Respiratory Infections
- Serum anti-IFN-I antibodies
- (no location specified)
Sep 12, 2022
Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- +2 more
- Mepolizumab 100 MG
-
Athens, Attiki, Greece
- +1 more
Sep 29, 2023
Covid19 Trial in Cairo (Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole, Drug:
Not yet recruiting
- Covid19
- Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole
- Drug: Isotretinoin(Aerosolized 13 cis retinoic acid)
-
Cairo, Kafr El-sheikh, EgyptKafr El-sheikh University
Oct 5, 2020
Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes
Recruiting
- Toxicity, Drug
- +2 more
- Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
Food Allergy, Food Hypersensitivity Trial in Erlangen (biopsy sampling)
Recruiting
- Food Allergy
- Food Hypersensitivity
- biopsy sampling
-
Erlangen, GermanyDepartment of Medicine 1, Hector Center for Nutrition, Exercise
Mar 11, 2022
Microvesicles and Monocytes to Predict Mortality of Cirrhosis
Active, not recruiting
- Cirrhosis
-
Bobigny, France
- +4 more
Jan 19, 2023
Methylation Pattern in Human Germ Cells of Patients Undergoing
Recruiting
- Female Infertility
- Gene Deregulation
-
Dortmund, NRW, GermanyInfertility treatment center Dortmund
Nov 16, 2022
Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)
Completed
- Prostate Cancer
- Intratumoral (IT) Poly ICLC 0.5 mg
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 8, 2022
Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)
Recruiting
- Metastatic Colorectal Cancer
- RO7122290
- +2 more
-
Toronto, Ontario, Canada
- +15 more
Jan 13, 2023
Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)
Recruiting
- Down Syndrome
- +5 more
-
Aurora, ColoradoLinda Crnic Institute for Down Syndrome
Jan 17, 2023
Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- rAd-IFN
- +2 more
-
Los Angeles, California
- +41 more
Oct 25, 2021
Neurotoxicity in Gastrointestinal Cancer Patients Receiving
Recruiting
- Gastrointestinal Cancer
- Folfox Protocol
-
Cairo, Abassia, EgyptAin shams university
Aug 8, 2022